1101 results about "Pill" patented technology

A device useful for oral drug delivery device consisting of: (a) a capsule, tablet or pill designed to disperse in the gastrointestinal system; (b) an RFID tag positioned in the capsule, tablet or pill, the RFID tag comprising an antenna; (c) an object selected from the group consisting of a magnet, a ferromagnetic object, a ferrite object and an electromagnetic shielding object positioned within, over or adjacent the antenna of the RFID tag to alter the antenna characteristics of the RFID tag so that if the RFID tag is interrogated before the capsule, tablet or pill disperses in the gastrointestinal system, the response of the RFID tag is sufficiently altered or attenuated to determine that the capsule, tablet or pill has not dispersed in the gastrointestinal system and so that if the RFID tag is interrogated after the capsule, tablet or pill has dispersed in the gastrointestinal system, the object separates from the RFID tag so that the response of the RFID tag is sufficiently detectable to determine that the capsule, tablet or pill has dispersed in the gastrointestinal system. Alternatively, a switch can be used to signal ingestion of the device, and change the response of the device. In another embodiment, the instant invention is a device useful for oral drug delivery, consisting of: (a) a capsule, tablet or pill designed to disperse in the gastrointestinal system; (b) a first non-anti-collision RFID tag positioned in the capsule; (c) a second non-anti-collision RFID tag positioned in the capsule, so that if the RFID tags are interrogated by an RFID reader before the capsule, tablet or pill disperses in the gastrointestinal system, the response of the RFID tags collide and so that after the dispersible material of the capsule has dispersed in the gastrointestinal system thereby allowing the first and second non-anti-collision tags to separate from each other, then the response of the RFID tags is sufficiently different from each other to determine that the capsule has dispersed in the gastrointestinal system

A device useful for oral drug delivery device consisting of: (a) a capsule, tablet or pill designed to disperse in the gastrointestinal system; (b) an RFID tag positioned in the capsule, tablet or pill, the RFID tag comprising an antenna; (c) an object selected from the group consisting of a magnet, a ferromagnetic object, a ferrite object and an electromagnetic shielding object positioned within, over or adjacent the antenna of the RFID tag to alter the antenna characteristics of the RFID tag so that if the RFID tag is interrogated before the capsule, tablet or pill disperses in the gastrointestinal system, the response of the RFID tag is sufficiently altered or attenuated to determine that the capsule, tablet or pill has not dispersed in the gastrointestinal system and so that if the RFID tag is interrogated after the capsule, tablet or pill has dispersed in the gastrointestinal system, the object separates from the RFID tag so that the response of the RFID tag is sufficiently detectable to determine that the capsule, tablet or pill has dispersed in the gastrointestinal system. Alternatively, a switch can be used to signal ingestion of the device, and change the response of the device.

The automated drug discrimination system inspects the drug being dispensed during the dispensing process so that the pharmacist can be certain the correct formulation, dosage and quality of pharmaceuticals were dispensed so the pharmacist does not need to spend as much time examining the dispensed drug. The pills are dispensed through a dispensing area using a dispensing apparatus and are collected in a collection area. At least two sensors take a plurality of measurements of an aggregate of the pills during the dispensing process or of each pill as it moves through the dispensing area. A discrimination system compares the measurements taken to verify that the pills dispensed are the type of pharmaceuticals intended to be dispensed as identified in the individual prescription for at least one of formulation and dosage of the pill.

A pharmaceutical preparation for the treatment of attention deficit disorders combines a therapeutically effective amount of digestive enzymes, such as chymotrypsin, and medication used to treat attention deficit disorders, such as Ritalin®, Concert®, Adderall® and Strattera®. The preparation may be in the form of a tablet, capsule or time released formula in order to reduce the amount of pills per dosage. The pharmaceutical preparation ameliorates the symptoms of the attention deficit disorder. The preparation has a stabilizing matrix containing a solidified microcrystalline cellulose which captures and protects therapeutically effective amounts of digestive enzyme particles within the stabilizing matrix.

A display for use on medical dispensing equipment, and the resulting medical device and its method of display. In particular, provided are a number of specific embodiments of such a display on a medical device, including a film display for use on pill bottles and pill dispensers that utilize colored images as a dosage reminder for the user, a conformable bistable reflective display for use on drug delivery devices, and a conformable bistable reflective display for use on blood glucose meters.

A prescription drug monitoring / dispensing device ensures prescription medication housed within is taken only as directed, and not abused or sold on the streets. The device serves as an intricately guarded casing that may only dispense the preprogrammed dosage amounts at preset times, as directed by a prescribing physician. The device may include a housing having a biometric finger scanner and a display screen in communication therewith, a loading tube capable of holding a pill therein, a rotating hub in communication with the loading tube, a rotating disc in communication with the loading tube, and an exit port capable of dispensing the pill out from the housing.

The automated drug discrimination system inspects the drug being dispensed during the dispensing process so that the pharmacist can be certain the correct formulation, dosage and quality of pharmaceuticals were dispensed so the pharmacist does not need to spend as much time examining the dispensed drug. The pills are dispensed through a dispensing area using a dispensing apparatus and are collected in a collection area. At least two sensors take a plurality of measurements of an aggregate of the pills during the dispensing process or of each pill as it moves through the dispensing area. A discrimination system compares the measurements taken to verify that the pills dispensed are the type of pharmaceuticals intended to be dispensed as identified in the individual prescription for at least one of formulation and dosage of the pill.

A pill container / dispenser that includes fingerprint recognition circuitry located in a cap associated therewith. The cap is locked on the container and no pill can be dispensed from the container without first moving the cap. When a person places their thumb on the cap of the pill dispenser, a computer chip reads the thumbprint. If the person is an authorized user, the cap will be unlocked from the container and released so a pill can be dispensed from the container. If the fingerprint is not recognized, the cap will remain locked in position so that no dispensing will occur. Furthermore, if the computer chip recognizes tampering, such as a continued effort to remove the cap by a non-authorized user, a chemical spray is sprayed from the cap into the container. The spray will dilute or destroy the potency of the pills remaining in the container.

The invention relates to highly concentrated DHA and EPA formulations in a soft gel capsule. A capsule may contain at least 80% omega-3 fatty acids, salts or derivatives thereof, where EPA and DHA are present in relative amounts of greater than or equal to 3:1 or less than or equal to 1:3, and constitute at least 75% to greater than 95% of the total fatty acids present in the capsule. Capsules of the invention may be provided in a blister package so as to provide clean and protected oils that are easy to travel with. Compliance is improved with one-pill-a-day dosing and the days of the week imprinted on the foil packing. Anitoxidant protection may be provided by rosemary and vitamin C. The invention also provides a methods of treatment, modulation or prophalaxis of coronary disease, altering serum LDL-cholesterol and / or HDL-cholesterol, lowering serum triglycerides, lowering blood pressure, pulse rate, altering the activity of the blood coagulation factor VII complex, mild hypertension, protection from cyclosporine toxicity in kidney transplant, rheumatoid arthritis, development and progression of retinopathy, hypertriglyceridemia, and neurological disorders in a subject.

A vacuum driven pill counter having a counter housing with a pill discharge aperture formed therein. vacuum disk is rotatably positioned in the housing and has a front wall including a pill aperture and an agitating finger extending outwardly from the front wall. A vacuum source is positioned in communication with the housing and is capable of drawing a vacuum through the pill aperture in the vacuum disk. A torque source is operatively connected to the vacuum disk in order to rotate the vacuum disk. A pill shelf is positioned adjacent to the front wall of the vacuum disk and a pill separator for removing pills retained on the pill apertures by the vacuum source is connected to the pill shelf. Finally, a pill sensor is positioned to detect pills which will exit the discharge aperture.

Method and identification system to keep track of individual pills dispensed to patients in a hospital by scanning a machine readable code assigned to each pill individually. The pills may be individually within single-pill containers. Inventory levels may be adjusted based on the scanning. Prior to dispensing the pills, a verification check may be performed.

A modular pillbox that includes a base unit and a plurality of modules that can be interchangeably coupled to the base unit. The base unit includes a plurality of interior compartments defined by a top, a bottom and at least one side wall, openable doors that close the tops of the plurality of interior compartments, one-way passages in one of the bottoms or the at least one side wall of each interior compartment through which pills can be pushed into the interior compartments, and an opening in a front portion of the base unit. The plurality of modules includes a cover plate that couples to the base unit and covers the opening, and various electronic packages that removable couple to the base unit and cover the opening. An interactive electronic pillbox that includes the platform or base unit and an electronics package includes data entry, data display, data transmitting and data processing functions which allow for interactive healthcare management by individuals and healthcare personnel directly or remotely. Form a remote location a healthcare provider can monitor, manage, evaluate and maintain a periodic record of the healthcare of a user of the electronic interactive pillbox.

A sealing sheet for use to close in a reversible manner a plurality of individual pill containers formed in a plastic sheet. The sealing sheet has a top layer, an adhesive layer and a peelable backing. The top layer and the adhesive layer are made of paper. The adhesive layer has a plurality of spaced apart holes punched therein, which are surrounded by adhesive layer bands having an upper surface that is covered with an upper layer of pressure sensitive adhesive glue and is attached by this glue to the top layer, and a lower surface covered with a lower layer of removable re-positionable pressure sensitive adhesive glue. The peelable backing also has a plurality of spaced apart holes that are positioned, shaped and sized to be in exact superimposition below the holes of the pressure sensitive adhesive glue layer. The holes of the backing are surrounded by backing bands having an upper surface detachably fixed to the lower surface of the adhesive layer bands by means of the lower layer of removable re-positionable pressure sensitive adhesive glue. In use, the backing bands can be peeled off from the pressure sensitive adhesive glue layer bands to allow fixation of the sealing sheet onto the container-defining sheet. Tearing lines are punched into both the top layer and the pressure sensitive adhesive glue layer bands in such a manner and position as to allow the top layer and pressure sensitive adhesive glue layer to be split into a number of cover pieces equal to the number of holes made in the pressure sensitive adhesive glue layer.

Methods include the injection of a gelled, gelling or gellable composition into a horizontal section of a well at a location, where produced well gases or a combination of well gases and injected gases are sufficient to move the pill through the horizontal section into heal section, sweeping the horizontal section of accumulated liquids. Once in the heal section, the pill and the accumulated liquids are uplifted to the surface resulting in a cleaned well.

A medication organizer system includes an arrangement of day of the week containers with each container divided into separate time of the day compartments. Each time of the day compartment has pictorial indicia which readily signifies a specific respective time of the day. A medication organized worksheet is provided with medication / pill identifying pictorial indicia and an imprinted grid which tracts the container and compartment arrangement; the grid having juxtaposed imprinted pictorial indicia corresponding to the compartment pictorial indicia. A sheet of adhesive backed peel-off numerals is provided, whereby a peeled-off numeral is adhered to the medication organizer worksheet juxtaposed to the grid and another peeled-off same numeral is adhered to the container for the specific medication. A medication organizer instruction sheet containing pictorials is provided to permit a layperson to readily use the medication organizer system.

A self-contained pill dispenser is disclosed. A housing is provided and a hopper for containing a plurality of pills is supported by the housing. A feed chute having a transport spiral therein is operatively connected to the hopper for receiving pills therefrom. The transport spiral has an outlet and controllable aperture. A vibrating plate is disposed proximate the outlet. A drive mechanism is connected to the vibrating plate for imparting vibration thereto. The drive mechanism can abruptly stop the vibration of the vibrating plate. A microcontroller is also operatively connected to the hopper, the transport spiral, and the drive mechanism. The system can self-calibrate the mechanism for counting and dispensing pills.

An intake to exit security system for high-volume pharmacies provides maximum security from tampering and assures accuracy. The system immediately assigns bar codes to shipments upon arrival and then tracks them through warehousing, bulk distribution, prescription dispensing and shipping to patients, hospitals and drugstores. Bar-coded lock neck devices secure bulk drug canisters to bar-coded dispensing machines at specified dispensing stations where the machines dispense drugs into pre-labeled prescription bottles according to prescription indicia on the labels. Bottles then undergo content analysis and certification before packaged and shipped to customers. A Ramon laser spectral analysis contrasts the bottle contents to a library of known spectral signatures of drugs, and the pharmacist is alerted to any detected difference. A simultaneously captured visual image of the pills enables the pharmacist visually to compare the contents to a library of known visual appearances of the drugs. Both analyses are recorded for prescriptions certified and forwarded to customers. Deviations are excised without disrupting flow of other prescriptions, and the system automatically reassigns an incorrectly filled prescription to another bottle which starts anew through the system. Full bottles of commonly used drugs and specialized containers for irregularly shaped objects, creams and ointments may be pre-filled and inventoried for later collation with prescription bottles at the packaging and shipping stage.

The present invention relates to gene therapy systems designed for the delivery of a therapeutic product to a subject using replication-defective virus composition(s) engineered with a built-in safety mechanism for ablating the therapeutic gene product, either permanently or temporarily, in response to a pharmacological agent—preferably an oral formulation, e.g., a pill. The invention is based, in part, on the applicants' development of an integrated approach, referred to herein as “PITA” (Pharmacologically Induced Transgene Ablation), for ablating a transgene or negatively regulating transgene expression. In this approach, replication-deficient viruses are used to deliver a transgene encoding a therapeutic product (an RNA or a protein) so that it is expressed in the subject, but can be reversibly or irreversibly turned off by administering the pharmacological agent; e.g., by administration of a small molecule that induces expression of an ablator specific for the transgene or its RNA transcript.

The present invention is a medication management system for use with a programmable mobile device, such as a cell phone, smart phone, or a tablet computer. The invention consists of a case that encases or attaches to the mobile device, with a pill container attached to the case, and software for execution by the mobile device to manage the use of medication, generally in the form of pills, by the user of the mobile device. The pill container slideably engages the case so that doses of pills in the container may be removed by sliding the container out far enough to expose the next dose of pills and turning the mobile device and case over. The software allows the user to program a dosing schedule into it and then alerts the user when it is time to take doses of pills.

A smart cap for a container to dispense a medication and for automatically (a) self-verifying at least an obverse side and a converse side of the medication once the smart cap has been programmed for the medication so as to prevent improper dispensing of the medication, (b) indicating and verifying the number of pills in the container, (c) indicating and verifying timely compliance for taking the medication as prescribed and (d) issuing instructions and / or warnings to the consumer. The cap includes necessary circuitry and displays and is programmable from computer.

A pill sorter with bag sealer designed for the dispensation and storage of easily transportable packages of medication. The pill sorter has one or more independent chambers that can store pills or other medication. The pill sorter dispenses medication through a funneled lid, allowing the user to dispense a single chamber's medication into a plastic bag. The plastic bag is placed into a bag sealer having an activation button, light-emitting diode (LED), battery, microprocessor, and sealing element. The activation time of the sealing element is adjusted by the microprocessor based upon the measured level of charge present in the battery, providing a one-touch sealing solution to the user. The sealing element seals the plastic bag, which has a perforated seal, allowing for easy opening of the plastic bag when the medication is needed.

A smart medicine container is provided to secure accesses to a bulk supply of pills stored therein and pills dispensed therein. The medicine container comprises a control unit, a memory, a communication interface unit, a pill-supply housing configured to store a bulk supply of pills, a pill-supply locking means configured to lock access to the pill-supply housing, a dispensing assembly configured to dispense pills from among the bulk supply of pills, and a dispensed-pill housing configured to receive and store dispensed pills, a dispensed-pill locking means configured to lock access to the dispensed-pill housing. The control unit is programmed to irreversibly cause the pill-supply locking means to lock access to the pill-supply housing and irreversibly cause the dispensed-pill locking means to lock access to the dispensed-pill housing when receiving information indicating that the bulk supply of pills should permanently discontinue to be taken by a patient.

An atypical pill dispensing apparatus. The atypical pill dispensing apparatus may include a pill depository, a pill transporter, and a controller. The pill depository accommodates atypical pills. The pill transporter includes: a housing including an inlet opening formed on one side to be provided with the atypical pills from the pill depository, and a discharging opening formed on the other side to discharge the atypical pills; a screw with one end disposed corresponding to the inlet opening and the other end disposed corresponding to the discharging opening so as to transport the atypical pills along a spiral when rotating; and a screw driver to rotate the screw. The controller enables the pill transporter to control the transportation of the atypical pills.

A self-contained pill dispenser is disclosed. A housing is provided and a hopper for containing a plurality of pills is supported by the housing. A feed chute is operatively connected to the hopper for receiving pills therefrom. The feed chute has an outlet and controllable aperture. A vibrating plate is disposed proximate the outlet. A drive mechanism is connected to the vibrating plate for imparting vibration thereto. The drive mechanism has a mechanism for abruptly stopping the vibration of the vibrating plate. A microcontroller is also operatively connected to the hopper, the feed chute, and the drive mechanism.

The invention relates to a slow-release micro drop whose active component is Humeitashen or other salt, wherein it is formed by element and film layer that controlling the drug release, whose weight ratio is 20:1-5:1; the Humeitashen content of element is 10-60%. The invention mainly uses protrusion method to prepare drop, and uses fluidize bed to pack.

The invention relates to a traditional Chinese medicine for curing mammary hyperplasia, which comprises oral administration Chinese traditional pills and external application plaster. The oral administration Chinese traditional pills comprise 23 Chinese herb medicines, while the external application plaster comprises 32 Chinese herb medicines. The ingredients of the traditional Chinese medicine formula is mixed compatibly and properly; the plaster and the oral administration pills of the invention can effectively cure the mammary hyperplasia caused by various reasons and has fast efficacy, short course of treatment, high cure rate and low cost. The traditional Chinese medicine of the invention has unique healing efficacy to breast adenofibroma, breast cancer, nipple discharge, mastalgia, mastitis, breast deformity, micromazia, osteomyelitis, femoral head necrosis, various sores, lymphoid tuberculosis and eye-mouth deviation.

The invention discloses a traditional Chinese medicine pill production device. The device comprises a sieve plate, a vibration motor, a cylinder, a second motor and a first motor. When pills fall on the top of the sieve plate after being prepared, the qualified pills fall into a discharging chamber through a discharging through hole formed in the sieve plate; the vibration motor vibrates and then drives the sieve plate to vibrate; the cylinder is used for pushing a push plate to move along the top of the sieve plate; a discharging channel is arranged to make unqualified pills which are discharged from a box fall into a receiving tank along the discharging channel; the second motor rotates and then drives spiral blades on a conveying rotary shaft to rotate, so that unqualified pills are conveyed from a feed inlet of a conveying device to a discharging opening of the conveying device, manpower is saved, and the production efficiency of equipment is improved; the first motor rotates and then drives crushing blades on a crushing rotary shaft to rotate so as to crush the unqualified pills.

A technique for assuring patient use of the correct drug pill for a prescribed treatment of a particular body organ or part, involving shaping the pill to have an appearance resembling such body organ—in particular, appropriate prophylactic-dose aspirin pills of heart-shape, as well as other drug pills for treating other body parts the shape of which is imparted to the respective pills.